Search hospitals > California > San Francisco
UCSF Helen Diller Family Comprehensive Cancer Center
Claim this profileSan Francisco, California 94115
Global Leader in Breast Cancer
Global Leader in Prostate Cancer
Conducts research for Brain Tumor
Conducts research for Cancer
Conducts research for Leukemia
423 reported clinical trials
13 medical researchers
Summary
UCSF Helen Diller Family Comprehensive Cancer Center is a medical facility located in San Francisco, California. This center is recognized for care of Breast Cancer, Prostate Cancer, Brain Tumor, Cancer, Leukemia and other specialties. UCSF Helen Diller Family Comprehensive Cancer Center is involved with conducting 423 clinical trials across 249 conditions. There are 13 research doctors associated with this hospital, such as Rahul Aggarwal, MD, Kieuhoa T. Vo, Hope Rugo, MD, and Pamela Munster.Area of expertise
1Breast Cancer
Global LeaderStage IV
Stage III
HER2 negative
2Prostate Cancer
Global LeaderStage IV
ATM positive
BRCA1 positive
Top PIs
Rahul Aggarwal, MDUniversity of California, San Francisco4 years of reported clinical research
Expert in Prostate Cancer
Studies Cancer
24 reported clinical trials
36 drugs studied
Kieuhoa T. VoUCSF Medical Center-Mission Bay2 years of reported clinical research
Expert in Tumors
Studies Neuroblastoma
21 reported clinical trials
31 drugs studied
Hope Rugo, MDUniversity of California San Francisco4 years of reported clinical research
Expert in Breast Cancer
Studies Cancer
19 reported clinical trials
45 drugs studied
Pamela MunsterUniversity of California, San Francisco3 years of reported clinical research
Expert in Tumors
Studies Solid Tumors
17 reported clinical trials
34 drugs studied
Clinical Trials running at UCSF Helen Diller Family Comprehensive Cancer Center
Breast Cancer
Solid Tumors
Cancer
Non-Small Cell Lung Cancer
Ovarian Cancer
Endometrial Cancer
Lung Cancer
Tumors
Prostate Cancer
Pancreatic Cancer
Gedatolisib + Fulvestrant +/- Palbociclib
for Advanced Breast Cancer
This is a Phase 3, open-label, randomized, clinical trial evaluating the efficacy and safety of gedatolisib plus fulvestrant with or without palbociclib for the treatment of patients with locally advanced or metastatic HR+/HER2- breast cancer following progression on or after CDK4/6 and aromatase inhibitor therapy.
Recruiting2 awards Phase 311 criteria
MDNA11 + Pembrolizumab
for Cancer
This is a Phase 1/2, multi-center, open-label, dose-escalation and expansion study to evaluate safety and tolerability, PK, pharmacodynamic, and early signal of anti-tumor activity of MDNA11 alone or in combination with a checkpoint inhibitor in patients with advanced solid tumors.
Recruiting1 award Phase 1 & 2
Elacestrant Combinations
for Breast Cancer
This is a multicenter, Phase 1b/2 trial. The phase 1b part of the trial aims to determine the RP2D of elacestrant when administered in combination with alpelisib, everolimus, palbociclib, abemaciclib, and ribociclib. The Phase 2 part of the trial will evaluate the efficacy and safety of the various combinations in patients with ER+/HER2- advanced/metastatic breast cancer.
Recruiting1 award Phase 1 & 2
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at UCSF Helen Diller Family Comprehensive Cancer Center?
UCSF Helen Diller Family Comprehensive Cancer Center is a medical facility located in San Francisco, California. This center is recognized for care of Breast Cancer, Prostate Cancer, Brain Tumor, Cancer, Leukemia and other specialties. UCSF Helen Diller Family Comprehensive Cancer Center is involved with conducting 423 clinical trials across 249 conditions. There are 13 research doctors associated with this hospital, such as Rahul Aggarwal, MD, Kieuhoa T. Vo, Hope Rugo, MD, and Pamela Munster.
Where is UCSF Helen Diller Family Comprehensive Cancer Center located?
The UCSF Helen Diller Family Comprehensive Cancer Center is located at 1600 Divisadero St, San Francisco, CA 94115. It is conveniently accessible by bus, with the nearest stop at Divisadero St & Sutter St, just a 1-minute walk away.
Who should I call to ask about financial aid or insurance network?
The UCSF Helen Diller Family Comprehensive Cancer Center provides comprehensive support services for patients and families dealing with cancer. For financial assistance, reach out to the Patient Estimate Program at (844) 678-6831 or [email protected] For insurance inquiries, contact Patient Financial Services at (866) 433-4035. For any general questions, email [email protected]
What insurance does UCSF Helen Diller Family Comprehensive Cancer Center accept?
The UCSF Helen Diller Family Comprehensive Cancer Center accepts a wide range of insurance plans, including private health insurance, Medicare Advantage, and Medi-Cal programs. UCSF Health has agreements with numerous health insurance companies, covering both preferred provider organizations (PPOs) and health maintenance organizations (HMOs). To determine your specific level of access to care at UCSF Health, please contact your health insurance company or your employer's benefit manager directly.
What awards or recognition has UCSF Helen Diller Family Comprehensive Cancer Center received?
The UCSF Helen Diller Family Comprehensive Cancer Center is renowned for its exceptional research, earning a spot as a top oncology hospital by Becker's Hospital Review. Its researchers have received prestigious awards including the NIH Director's New Innovator Award, the Brian G.M. Durie Outstanding Achievement Award, and the Vollum Award for Distinguished Accomplishment in Science and Technology. Additionally, the center oversees a comprehensive intramural awards program, supporting pilot projects through CCSG developmental, foundation, and philanthropic funds.